GELITA Targets Gelatine for Soft Capsules

11 Apr 2017 --- Collagen proteins manufacturer GELITA is to present RXL R², a gelatine for soft capsules with fast fill release performance, at this year’s Vitafoods Europe. GELITA RXL R² has taken the reduced cross-linking concept provided by GELITA RXL one step further and brings revolutionary release (R²) performance to the market (3 times faster fill release compared to standard gelatine).

Trials clearly show that even under demanding storage conditions (6 months at 40C° and 75% r.h.), capsules with GELITA RXL R² offer an identical fill release profile to fresh capsules, the company says.

GELITA will also be showcasing the most up-to-date scientific evidence in collagen peptide research. With new study results being available in the fields of mobility, body toning, beauty from within and wound healing, GELITA strengthens its position as a partner for the development of innovative supplements and functional food products with proven efficacy.

With their special nutritional and technological properties, Bioactive Collagen Peptides are enjoying increasing popularity in the food and dietary supplements market. New research on knee pain reduction in athletes and osteoporosis prevention in postmenopausal women has once again underlined the effectiveness of GELITA's FORTIGEL and FORTIBONE. By stimulating the body’s own cells to strengthen the structure of joints and bones, these specific collagen peptides operate from within and help people to stay active and mobile at every life stage. 

A recent study with GELITA’s BODYBALANCE revealed a significant increase in fat-free body mass after resistance exercise and BODYBALANCE supplementation compared to placebo. Furthermore, collagen peptide treatment led to significant fat mass reduction, whereas muscle strength and waist circumference improved after intake. 

In recent years, a series of clinical studies have shown that supplementation with VERISOL collagen peptides leads to long-term improvements in skin health. Now, the first ever clinical trial has investigated the efficacy of VERISOL supplementation on nail growth and brittle nail syndrome. This study showed that supplementation led to clear improvements, and 8 out of 10 participants were satisfied with the performance of the treatment. 

By influencing collagen metabolism directly from the inside, VERISOL gives the skin its firm structure and is essential for skin elasticity and resistance. That it can also improve the wound healing process after surgery has now been shown in novel research. Patients treated with VERISOL clearly showed better wound healing results than the placebo group.